Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Zheng, W.
Right arrow Articles by Blaner, W. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zheng, W.
Right arrow Articles by Blaner, W. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences 61, 107-114 (2001)
Copyright © 2001 by the Society of Toxicology


NEUROTOXICOLOGY

Transthyretin, Thyroxine, and Retinol-Binding Protein in Human Cerebrospinal Fluid: Effect of Lead Exposure

Wei Zheng*,{dagger},1, Yong-Ming Lu{ddagger}, Guo-Yao Lu{ddagger}, Qiuqu Zhao*, Onpan Cheung* and William S. Blaner§

* Division of Environmental Health Sciences, School of Public Health, {dagger} Departments of Pharmacology and § Medicine, College of Physicians and Surgeons, Columbia University, New York, New York 10032; and {ddagger} Department of Neurosurgery, Hangzhou First Hospital, Hangzhou, Zhejiang 310006, People's Republic of China

Transthyretin (TTR), synthesized by the choroid plexus, is proposed to have a role in transport of thyroid hormones in the brain. Our previous studies in animals suggest that sequestration of lead (Pb) in the choroid plexus may lead to a marked decrease in TTR levels in the cerebrospinal fluid (CSF). The objectives of this study were to establish in humans whether TTR and thyroxine (T4) are correlated in the CSF, and whether CSF levels of Pb are associated with those of TTR, T4, and/or retinol-binding protein (RBP). Eighty-two paired CSF and blood/serum samples were collected from patients undergoing clinical diagnosis of CSF chemistry. Results showed that the mean value of CSF concentrations for TTR was 3.33 ± 1.60 µg/mg of CSF proteins (mean ± SD, n = 82), for total T4 (TT4) was 1.56 ± 1.68 ng/mg (n = 82), for RBP was 0.34 ± 0.19 µg/mg (n = 82), and for Pb was 0.53 ± 0.69 µg/dl (n = 61 for those above the detection limit). Linear regression analyses revealed that CSF TTR levels were positively associated with those of CSF TT4 (r = 0.33, p < 0.005). CSF TTR concentrations, however, were inversely associated with CSF Pb concentrations (r = –0.29, p < 0.05). There was an inverse, albeit weak, correlation between CSF TT4 and CSF Pb concentrations (r = –0.22, p = 0.09). The concentrations of TTR, TT4, and Pb in the CSF did not vary as the function of their levels in blood or serum, but RBP concentrations in the CSF did correlate to those of serum (r = 0.39, p < 0.0005). Unlike TTR, CSF RBP concentrations were not influenced by Pb. These human data are consistent with our earlier observations in animals, which suggest that TTR is required for thyroxine transport in the CSF and that Pb exposure is likely associated with diminished TTR levels in the CSF.

Key Words: transthyretin; thyroxine; retinol-binding protein; lead; cerebrospinal fluid; choroid plexus.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
E. Diamanti-Kandarakis, J.-P. Bourguignon, L. C. Giudice, R. Hauser, G. S. Prins, A. M. Soto, R. T. Zoeller, and A. C. Gore
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
Endocr. Rev., June 1, 2009; 30(4): 293 - 342.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
L. Z. Shi and W. Zheng
Early lead exposure increases the leakage of the blood-cerebrospinal fluid barrier, in vitro
Human and Experimental Toxicology, March 1, 2007; 26(3): 159 - 167.
[Abstract] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
N. A. Kassem, R. Deane, M. B. Segal, and J. E. Preston
Role of transthyretin in thyroxine transfer from cerebrospinal fluid to brain and choroid plexus
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2006; 291(5): R1310 - R1315.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
R. L. Chen, S. B. P. Athauda, N. A. Kassem, Y. Zhang, M. B. Segal, and J. E. Preston
Decrease of Transthyretin Synthesis at the Blood-Cerebrospinal Fluid Barrier of Old Sheep
J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2005; 60(7): 852 - 858.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
L. Quadro, W. S. Blaner, L. Hamberger, P. M. Novikoff, S. Vogel, R. Piantedosi, M. E. Gottesman, and V. Colantuoni
The role of extrahepatic retinol binding protein in the mobilization of retinoid stores
J. Lipid Res., November 1, 2004; 45(11): 1975 - 1982.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
T. I. Lidsky and J. S. Schneider
Lead neurotoxicity in children: basic mechanisms and clinical correlates
Brain, January 1, 2003; 126(1): 5 - 19.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.